Vontobel Holding Ltd. Purchases New Shares in Astera Labs, Inc. (NASDAQ:ALAB)

Vontobel Holding Ltd. purchased a new stake in Astera Labs, Inc. (NASDAQ:ALABFree Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 20,420 shares of the company’s stock, valued at approximately $2,705,000.

A number of other institutional investors have also made changes to their positions in the business. Legato Capital Management LLC raised its holdings in shares of Astera Labs by 68.2% in the fourth quarter. Legato Capital Management LLC now owns 25,612 shares of the company’s stock valued at $3,392,000 after buying an additional 10,386 shares during the last quarter. Peterson Wealth Services acquired a new stake in Astera Labs in the fourth quarter worth about $1,208,000. Essex Financial Services Inc. increased its position in Astera Labs by 1.9% in the fourth quarter. Essex Financial Services Inc. now owns 24,939 shares of the company’s stock worth $3,303,000 after purchasing an additional 468 shares during the period. Comprehensive Financial Planning Inc. PA acquired a new stake in Astera Labs in the fourth quarter worth about $250,000. Finally, Entropy Technologies LP acquired a new stake in Astera Labs in the fourth quarter worth about $1,742,000. 60.47% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of research reports. Citigroup initiated coverage on Astera Labs in a research report on Monday, November 18th. They issued a “buy” rating and a $120.00 price objective for the company. Roth Mkm lifted their price objective on Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Barclays lifted their price objective on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a research report on Friday, January 17th. Stifel Nicolaus lifted their price objective on Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $115.33.

Check Out Our Latest Stock Report on ALAB

Astera Labs Trading Down 0.4 %

NASDAQ:ALAB opened at $87.85 on Monday. Astera Labs, Inc. has a fifty-two week low of $36.22 and a fifty-two week high of $147.39. The business’s 50-day simple moving average is $120.17 and its 200-day simple moving average is $83.51.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post -0.45 EPS for the current year.

Insider Activity

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $105.90, for a total value of $3,177,000.00. Following the sale, the director now owns 3,765 shares in the company, valued at approximately $398,713.50. The trade was a 88.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Manuel Alba sold 11,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total value of $1,292,500.00. Following the completion of the sale, the director now owns 456,863 shares in the company, valued at $53,681,402.50. The trade was a 2.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 639,244 shares of company stock worth $67,669,886 in the last 90 days.

Astera Labs Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.